Acadian Asset Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Acadian Asset Management's GOSS Position: Q2 2026 in Review
Acadian Asset Management reduced its Gossamer Bio (GOSS) stake by 66% in Q2 2026, selling an estimated $973K and leaving 1,792,135 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.
Acadian Asset Management first reported a position in GOSS in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.7M in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Acadian Asset Management held 1,792,135 shares of Gossamer Bio worth $293K as of Q2 2026.
- Acadian Asset Management sold 3,485,769 Gossamer Bio shares in Q2 2026, an estimated $973K.
- Gossamer Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1568 holding.
- Acadian Asset Management first reported a position in Gossamer Bio in Q4 2022 and has held it in 15 quarters since.
- Acadian Asset Management's Gossamer Bio position peaked at $13.7M in Q4 2025.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.